A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors
Clinical trial NCT04921878 · COMPLETED
Trial details
- NCT number
- NCT04921878
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2023-04-03
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.